<DOC>
	<DOCNO>NCT01215409</DOCNO>
	<brief_summary>In uncontrolled , non-randomized , prospective , local post-marketed surveillance study , data obtain safety efficacy LEVITRA® routine treatment erectile dysfunction . The general objective evaluate product safety ( primarily record adverse event ) , efficacy patient acceptance .</brief_summary>
	<brief_title>Real Life Safety Efficacy Vardenafil</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Any adult patient ( &gt; /=18 year ) erectile dysfunction treat LEVITRA® . Patients must able give write informed consent participation study receive detailed write oral information prior study . Exclusion criterion must read conjunction product information ( Package Insert ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Levitra</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Taiwan</keyword>
</DOC>